AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

948.449

+8.1980.87%

Number of Gainers:11

Number of Losers:8

Number of Flat:13

PE:- -

High:951.222

Open:940.198

Low:940.198

Close:940.250

Volume:17.18M

Turnover:86.00M

Market Cap:243.17B

Float Cap:189.75B

Loading ...

BUZZ-CSL's Memo deal signals new R&D philosophy, Jefferies says

BRIEF-Memo Therapeutics AG Enters Into A Collaboration And Option Agreement With Csl For Development Of Recombinant Polyclonal Igg Technology

Memo Therapeutics Ag Enters Into a Collaboration and Option Agreement With CSL for Development of Recombinant Polyclonal Igg Technology

THOMSON REUTERS

Memo Therapeutics Ag: Agreement Includes R&D Funding for Exploratory Work, Technology Access

THOMSON REUTERS

Memo Therapeutics Ag: Co Will Develop Recombinant Polyclonal Igg Using Dropzylla Platform to Clone Antibody Repertoires,Express Antibodies

THOMSON REUTERS

Domino's Pizza, Flight Centre Preferred Consumer Companies Ahead of Fiscal H1 Results, Jefferies Says

MT Newswires Live

ResMed (RMD) Is Up 5.2% After Strong Quarter, Dividend Hike And Completed Buyback Program

Simply Wall St.

ASX Opportunities: Aroa Biosurgery And 2 Other Promising Penny Stocks

Simply Wall St.

Assessing Woolworths Group (ASX:WOW) Valuation As Board Changes Signal A Digital Shift

Simply Wall St.

Seqirus Spin-off Pause and Flu Demand Concerns Could Be A Game Changer For CSL (ASX:CSL)

Simply Wall St.

Is American Tower (AMT) Offering Value After Recent Share Price Weakness?

Simply Wall St.

IDX Aims to Roll Out Free-Float Stock Regulations in March

ResMed Director Sells 2,000 Shares

MT Newswires Live

Coles Group Approaches Deadline to Pay ACCC Phase Two Review Fees for Western Australia Supermarket, Liquor Site Acquisition

MT Newswires Live

ASX Biggest Gainers

MT Newswires Live

DIARY-Australia, New Zealand corporate earnings week ahead

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

Genetic Signatures Ltd-Gss Appoints Anne Lockwood as Interim Managing Director

THOMSON REUTERS

ASX Growth Companies With High Insider Stakes To Watch

Simply Wall St.

Mesoblast (ASX:MSB) Is Down 7.4% After Expanding Ryoncil Access And Planning Adult SR-aGvHD Trial – Has The Bull Case Changed?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7501/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":948.44867,"timestamp":1770686131361,"preClose":940.2503,"halted":0,"volume":17184486,"delay":0,"changeRate":0.008719,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":8.198364,"latestTime":"02-10 12:15:31 AEDT","open":940.19763,"high":951.2218,"low":940.19763,"amount":86003137,"amplitude":0.011725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1770678000000,1770699600000]],"turnoverRate":0.001197,"increases":11,"decrements":8,"flats":13,"marketCap":243168962217.25,"floatMarketCap":189754248094.33594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":951.2218,"amplitude":0.011725,"preClose":940.2503,"low":940.19763,"latestPrice":948.44867,"volume":17184486,"delay":0,"open":940.19763,"prevYearClose":900.1661,"prevWeekClose":933.307,"prevMonthClose":933.794,"prevQuarterClose":900.166,"fiveDayClose":932.396,"twentyDayClose":914.479,"sixtyDayClose":920.438,"secType":"PLATE","market":"AU","turnoverRate":0.001197,"marketCap":243168962217.25,"floatMarketCap":189754248094.33594,"timestamp":1770686131361,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":11,"down":8,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610683756","title":"BUZZ-CSL's Memo deal signals new R&D philosophy, Jefferies says","url":"https://stock-news.laohu8.com/highlight/detail?id=2610683756","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610683756?lang=en_us&edition=fundamental","pubTime":"2026-02-10 02:40","pubTimestamp":1770662451,"startTime":"0","endTime":"0","summary":"BUZZ-CSL's Memo deal signals new R&D philosophy, Jefferies says** Jefferies says Australia's CSL CSL.AX sees its new agreement with Switzerland-based Memo Therapeutics as \"evidence\" that the biotech major is now focusing on development by buying assets into its pipeline** Memo on Monday said it entered into a collaboration and option agreement with CSL for development of recombinant polyclonal IgG technology, a method used to clone antibodies** Jefferies notes CSL is looking to reenergise its research function in the longer term; however, flags it will likely take time, given the nature of R&D** Brokerage adds Memo deal could help with CSL's product growth in the medium term, following co's VarmX deal last year** CSL up 4.5% so far this year, as of last close","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nL4N3Z51TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7511","BK7508","CSL.AU"],"gpt_icon":0},{"id":"2610637722","title":"BRIEF-Memo Therapeutics AG Enters Into A Collaboration And Option Agreement With Csl For Development Of Recombinant Polyclonal Igg Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2610637722","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610637722?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:18","pubTimestamp":1770639539,"startTime":"0","endTime":"0","summary":"BRIEF-Memo Therapeutics AG Enters Into A Collaboration And Option Agreement With Csl For Development Of Recombinant Polyclonal Igg TechnologyFeb 9 (Reuters) - CSL Ltd CSL.AX:MEMO THERAPEUTICS AG ENTER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z515R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7508","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2610463745","title":"Memo Therapeutics Ag Enters Into a Collaboration and Option Agreement With CSL for Development of Recombinant Polyclonal Igg Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2610463745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610463745?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:09","pubTimestamp":1770638958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z515R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","CSL.AU","BK7508","BK7511"],"gpt_icon":0},{"id":"2610374296","title":"Memo Therapeutics Ag: Agreement Includes R&D Funding for Exploratory Work, Technology Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2610374296","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610374296?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:09","pubTimestamp":1770638958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z515R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","CSL.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2610266637","title":"Memo Therapeutics Ag: Co Will Develop Recombinant Polyclonal Igg Using Dropzylla Platform to Clone Antibody Repertoires,Express Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2610266637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610266637?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:09","pubTimestamp":1770638958,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z515R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","BK7508","BK7067","CSL.AU"],"gpt_icon":0},{"id":"2610502059","title":"Domino's Pizza, Flight Centre Preferred Consumer Companies Ahead of Fiscal H1 Results, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2610502059","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610502059?lang=en_us&edition=fundamental","pubTime":"2026-02-09 11:03","pubTimestamp":1770606200,"startTime":"0","endTime":"0","summary":"Domino's Pizza  is a preferred consumer company for Jefferies due to high short interest and potential upside from cost reduction initiatives, while Flight Centre  is also preferred due to opportunities to gain market share in corporate travel, according to a Feb. 6 note by the investment firm.Jefferies said there is downside risk for JB Hi-Fi , especially its subsidiary The Good Guys, due to aggressive discounting, demanding comparable sales bases, and market share gains by Harvey Norman .Woolworths Group  has likely regained some sales momentum, but this appears to have required significant investment, the note added.According to Jefferies, most consumer-facing companies are facing challenging conditions with intensified competition in the supermarket sector, while discount retail conditions weakened in December, likely compounded by the interest rate increase in February.DMP shares were up 2%, and FLT was up 6% in recent Monday trade, while JBH fell almost 1%, and WOW gained nearly ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK7070","JBH.AU","BK7040","BK7153","BK7001","BK4588","BK7041","FLT.AU","DPZ","BK7511","BK4209","BK4585","BK7137","BK4559","HVN.AU","BK7501","BK4524","WOW.AU","DMP.AU"],"gpt_icon":0},{"id":"2610505087","title":"ResMed (RMD) Is Up 5.2% After Strong Quarter, Dividend Hike And Completed Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2610505087","media":"Simply Wall St.","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610505087?lang=en_us&edition=fundamental","pubTime":"2026-02-09 07:15","pubTimestamp":1770592543,"startTime":"0","endTime":"0","summary":"In late January 2026, ResMed reported higher quarterly sales of US$1,422.81 million and net income of US$392.59 million, alongside declaring a US$0.60 per-share quarterly dividend payable on March 19, 2026, and confirming completion of a multi-year US$1.19 billion share buyback program.\nBeyond the headline results, management highlighted strong global demand for masks and devices, expanding digital health software, and supply-chain efficiencies that supported margin expansion during the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/resmed-rmd-is-up-52-after-strong-quarter-dividend-hike-and-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/resmed-rmd-is-up-52-after-strong-quarter-dividend-hike-and-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RMD.AU","BK4567","IE00B5TLWC47.USD","LU2008162690.USD","LU2177674079.SGD","BK4585","BK7007","BK4588","RMD","LU0170899867.USD","BK7501","BK4082","BK4548","BK4504"],"gpt_icon":0},{"id":"2610505033","title":"ASX Opportunities: Aroa Biosurgery And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2610505033","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610505033?lang=en_us&edition=fundamental","pubTime":"2026-02-09 03:02","pubTimestamp":1770577340,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a challenging period, with a significant downturn influenced by global market pressures and recent tech selloffs. Despite the turbulence, investors often seek opportunities in penny stocks, which can offer unique value propositions when backed by strong financials. These smaller or newer companies may present potential for growth and stability, making them intriguing options for those looking to uncover hidden gems in the stock market.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cyp/cynata-therapeutics-shares/news/asx-opportunities-aroa-biosurgery-and-2-other-promising-penn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cyp/cynata-therapeutics-shares/news/asx-opportunities-aroa-biosurgery-and-2-other-promising-penn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SSM.AU","BK7503","AAL.AU","BK7067","BK7095","BK7506","WAF.AU","BK7501","IGL.AU","MXI.AU","BK7062","MTO.AU","BK7045","BK7143","CYP.AU","AEF.AU","BK7128","BK7050","BK7016","ARX.AU","PPS.AU","VRS.AU","BK7077","BK7104","BK7055","DSK.AU","BVR.AU","BK7508"],"gpt_icon":0},{"id":"2609520488","title":"Assessing Woolworths Group (ASX:WOW) Valuation As Board Changes Signal A Digital Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2609520488","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609520488?lang=en_us&edition=fundamental","pubTime":"2026-02-08 10:11","pubTimestamp":1770516699,"startTime":"0","endTime":"0","summary":"Board changes and why they matter for Woolworths Group (ASX:WOW) investors\nWoolworths Group (ASX:WOW) has flagged a governance shift, with experienced technology and product leader Jon Alferness joining the Board as a non executive director, while Tracey Fellows plans to retire from the Board.\nSee our latest analysis for Woolworths Group.\nAt a share price of A$31.45, Woolworths Group has recorded a 30 day share price return of 6.43% and a 1 year total shareholder return of 8.2%, while the 3...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/assessing-woolworths-group-asxwow-valuation-as-board-changes","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/assessing-woolworths-group-asxwow-valuation-as-board-changes","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","BK7501","DCF","WOW.AU","BK7040","BK4100","WOW"],"gpt_icon":0},{"id":"2609446795","title":"Seqirus Spin-off Pause and Flu Demand Concerns Could Be A Game Changer For CSL (ASX:CSL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609446795","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609446795?lang=en_us&edition=fundamental","pubTime":"2026-02-07 12:21","pubTimestamp":1770438096,"startTime":"0","endTime":"0","summary":"In recent weeks, CSL has been in focus as investors look back on its February 11 half-year results and interim dividend announcement, following earlier cuts to its fiscal 2026 growth outlook and a pause to the planned Seqirus vaccines spin-off after weaker US flu vaccination rates.\nAt the same time, CSL has faced regulatory scrutiny over Tavneos data in Europe and tougher competition for its Vifor iron products, sharpening attention on how well the group can balance growth ambitions with...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/seqirus-spin-off-pause-and-flu-demand-concerns-could-be-a-ga","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/seqirus-spin-off-pause-and-flu-demand-concerns-could-be-a-ga","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","LU0728928796.USD","BK7511","BK7508","CSL.AU","BK4023","BK4086","BK4585","CSL","BK7501","BK4528","LU1169590202.USD","BK4543","BK4587","SGXZ23171101.USD","BK4551","BK4588","BK7067","LU1169589451.USD","AI"],"gpt_icon":0},{"id":"2609512869","title":"Is American Tower (AMT) Offering Value After Recent Share Price Weakness?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609512869","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609512869?lang=en_us&edition=fundamental","pubTime":"2026-02-07 02:14","pubTimestamp":1770401653,"startTime":"0","endTime":"0","summary":"If you are wondering whether American Tower's current share price reflects its underlying worth, you are not alone; many investors are asking the same question right now.\nThe stock last closed at US$171.49, with returns of 5.4% decline over 7 days, 2.5% decline over 30 days, 1.9% decline year to date and 6.5% decline over the past year, alongside 11.8% decline over 3 years and 12.8% decline over 5 years.\nRecent news coverage around American Tower has focused on its role in providing wireless...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/is-american-tower-amt-offering-value-after-recent-share-pric","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/is-american-tower-amt-offering-value-after-recent-share-pric","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK4581","BK4084","AMT.AU","BK7007","BK4219","DCF","BK4554","AMT","BK4585","BK4534","BK4588"],"gpt_icon":0},{"id":"2609565989","title":"IDX Aims to Roll Out Free-Float Stock Regulations in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2609565989","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609565989?lang=en_us&edition=fundamental","pubTime":"2026-02-06 14:53","pubTimestamp":1770360813,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta- Indonesia Stock Exchange  will adjust stock listing rules, including free float requirements. These new provisions will be included in the amendments to Regulation Number I-A regarding the Listing of Shares and Equity Securities Other than Shares Issued by Listed Companies.\"The implementation of these regulatory adjustments is planned for March 2026,\" said IDX Corporate Secretary Kautsar Primadi Nurahmad in an official statement quoted on Friday, February 6, 2026. The adjustments include raising the minimum free float requirement to 15 percent from the previous 7.5 percent. These provisions will be implemented gradually, with specific targets set for each stage.Additionally, the rule changes involve improving corporate governance by implementing continuous education obligations for the boards of directors, commissioners, and audit committees of listed companies. Furthermore, directors and those one level below the board of directors are required to be competent in ac","market":"us","thumbnail":"https://statik.tempo.co/data/2026/01/30/id_1456158/1456158_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/01/30/id_1456158/1456158_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2085502/idx-aims-to-roll-out-free-float-stock-regulations-in-march","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2085502/idx-aims-to-roll-out-free-float-stock-regulations-in-march","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4563","BK7501","IDX.AU","APEI","IDX","AEI.AU","BK4024","BK7047","BK7124","AEI","BK4204"],"gpt_icon":0},{"id":"2609555597","title":"ResMed Director Sells 2,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609555597","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609555597?lang=en_us&edition=fundamental","pubTime":"2026-02-06 13:17","pubTimestamp":1770355031,"startTime":"0","endTime":"0","summary":"ResMed's (ASX:RMD) director Peter Farrell sold 2,000 of the company's common shares for an aggregate market value of $502,540 on Wednesday, according to a US Securities and Exchange Commission disclosure filed with the Australian bourse on Friday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0170899867.USD","RMD.AU","BK7007","LU2177674079.SGD","BK4504","BK4585","BK4588","IE00B5TLWC47.USD","BK4548","BK7501","LU2008162690.USD","RMD","BK4567","BK4082"],"gpt_icon":0},{"id":"2609558281","title":"Coles Group Approaches Deadline to Pay ACCC Phase Two Review Fees for Western Australia Supermarket, Liquor Site Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2609558281","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609558281?lang=en_us&edition=fundamental","pubTime":"2026-02-06 12:16","pubTimestamp":1770351370,"startTime":"0","endTime":"0","summary":"Coles Group  is required to pay the Australian Competition and Consumer Commission's  phase two review fee for the proposed leasehold interest acquisition of a Western Australia supermarket and liquor site in Somerville by Feb. 9 if it wishes to continue with the review, according to a notification from the regulator.In November last year, the supermarket giant lodged a notification with the ACCC regarding Coles Supermarkets Australia's proposed acquisition. The ACCC decided late last month that the acquisition be subject to a phase two review after determining that the deal could lead to a substantial lessening of competition in a market.If the fee is not paid by Feb. 9, the ACCC will cease considering the notification. The determination period will end on June 12.Coles' shares fell nearly 1% in recent trading on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7501","XKO.AU","BK4168","BK7040","BK7082","COL.AU","WRN","XJO.AU"],"gpt_icon":0},{"id":"2609532874","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2609532874","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609532874?lang=en_us&edition=fundamental","pubTime":"2026-02-06 10:25","pubTimestamp":1770344732,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest gains on Friday.Liberty Financial Group : +5%, AU$4.13ResMed : +2%, AU$38.24Brambles : +2%, AU$23.13Smartgroup : +1%, AU$8.60PEXA Group : +1%, AU$13.75Gryphon Capital Income Trust : +1%, AU$2.08Rio Tinto Group : +1%, AU$158Woolworths Group : +1%, AU$31.78Aussie Broadband : +0.5%, AU$4.37National Storage REIT : +0.2%, AU$2.76","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PXA.AU","ABB.AU","BK7501","BK7160","BK7151","BK7007","BK7095","BK7511","NSR.AU","BK7004","SIQ.AU","RIO.AU","BK7123","GCI.AU","BK7015","BK7010","BK7507","BK7057","RMD.AU","BK7064","BK7040","LFG.AU","WOW.AU","BXB.AU"],"gpt_icon":0},{"id":"2609653957","title":"DIARY-Australia, New Zealand corporate earnings week ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2609653957","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609653957?lang=en_us&edition=fundamental","pubTime":"2026-02-06 09:00","pubTimestamp":1770339600,"startTime":"0","endTime":"0","summary":"DIARY-Australia, New Zealand corporate earnings week aheadFeb 6 (Reuters) - Diary of Australia and New Zealand (.AXJO, .NZ50) corporate earnings for the week ahead AUSTRALIA & NEW ZEALAND EARNINGS Sta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4N3Z11DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7006","BK7501","ARF.AU","BK7506","COH.AU","S32.AU","AMP.AU","BK7094","CSL.AU","PME.AU","SGH.AU","IAG.AU","NCK.AU","BK4135","BK7119","CLW.AU","GQG.AU","GQPIL","TPW.AU","WBC.AU","HDN.AU","BK7112","BK7005","AGL.AU","BK7162","BK7511","CBA.AU","BK7507","BK7099","BK7136","BK7120","BK7165","NST.AU","BK7508","BK7062","BK7107","BRG.AU","CIP.AU","BK4011","BK7067","BK7095","EVN.AU","BK7135","BK7130","ORG.AU","JHX","BK7034","BK7049","BK7031","BK7007"],"gpt_icon":0},{"id":"2609538890","title":"Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2609538890","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609538890?lang=en_us&edition=fundamental","pubTime":"2026-02-06 06:37","pubTimestamp":1770331020,"startTime":"0","endTime":"0","summary":"2237 GMT - Supermarket chain Woolworths's profit margin has likely come under pressure, setting it up to miss consensus expectations in 1H, contends Morgan Stanley. Woolworths's food business in Australia likely experienced a contraction of 30 basis points in its 1H gross profit margin. That reflects a significant step up in promotional activity in 2Q, analyst Melinda K. Baxter says. Woolworths doesn't have many levers to offset that impact in the near term. MS suggests Woolworths's share price could fall by mid-single-digit percent if it's right. It retains an equal-weight call and A$31.30/share price target on Woolworths, which ended Thursday at A$31.61. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU0106831901.USD","LU0314104364.USD","BK7511","LU0225283273.USD","LU0098860793.USD","IE00BZ1G4Q59.USD","BK4504","BK4127","BK4534","LU1162221912.USD","LU1732799900.SGD","LU1989772840.SGD","LU2133065610.SGD","LU0971096721.USD","LU1244550221.USD","LU0795875086.SGD","LU2111349929.HKD","LU0106261372.USD","IE00BKVL7J92.USD","LU1244550577.SGD","BK4581","LU2271345857.HKD","LU1548497426.USD","LU2357305700.SGD","LU1791710400.SGD","LU0795875169.SGD","LU0882574139.USD","LU1720051108.HKD","LU1791710582.SGD","LU0557290698.USD","LU0158827781.USD","LU0912757837.SGD","BK7501","LU1074936037.SGD","LU2028103732.USD","LU2023251221.USD","WOW.AU","LU1989772923.USD","LU2089283258.USD","LU1244550494.USD","BK4588","LU0234570918.USD","BK4516","LU0158827948.USD","LU1732800096.USD","LU0267386448.USD","LU1363072403.SGD","LU0320765646.SGD","BK7040"],"gpt_icon":0},{"id":"2609840445","title":"Genetic Signatures Ltd-Gss Appoints Anne Lockwood as Interim Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2609840445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609840445?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:20","pubTimestamp":1770326416,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nTUE1ZQZGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2609538068","title":"ASX Growth Companies With High Insider Stakes To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2609538068","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609538068?lang=en_us&edition=fundamental","pubTime":"2026-02-06 03:08","pubTimestamp":1770318490,"startTime":"0","endTime":"0","summary":"As the Australian market faces a slightly lower opening amid global tech sector challenges, investors are increasingly cautious, influenced by Wall Street's recent downturn and upcoming central bank meetings. In this climate, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-emr/emerald-resources-shares/news/asx-growth-companies-with-high-insider-stakes-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-emr/emerald-resources-shares/news/asx-growth-companies-with-high-insider-stakes-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7116","BK7067","NWF.AU","LM8.AU","WZR.AU","BK7093","AV1.AU","BK7117","BK7506","CAT.AU","BK7036","BK7095","BK7501","3DP.AU","BK7104","ELS.AU","BK7016","SEA.AU","AEM.AU","TTT.AU","MSB.AU","BK7084","EIQ.AU","BK7017","BK7508","EMR.AU"],"gpt_icon":0},{"id":"2609301714","title":"Mesoblast (ASX:MSB) Is Down 7.4% After Expanding Ryoncil Access And Planning Adult SR-aGvHD Trial – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609301714","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609301714?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:25","pubTimestamp":1770290755,"startTime":"0","endTime":"0","summary":"Mesoblast Limited reported past real-world use of Ryoncil (remestemcel-L-rknd) in pediatric steroid-refractory acute graft-versus-host disease, alongside expanding U.S. transplant center onboarding and broad government and commercial reimbursement coverage via a dedicated MyMesoblast access hub and a specific CMS J-Code.\nThe company also plans to widen Ryoncil’s label into the much larger adult SR-aGvHD population through a pivotal trial with the NIH-funded Bone Marrow Transplant Clinical...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-down-74-after-expanding-ryoncil-access-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-down-74-after-expanding-ryoncil-access-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU","BK7501","MSB","BK7508","BK4006","BK7067","SR","BK4197"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":84,"code":"91000000","status":"200"}]}}